Clinical and pathophysiological delineation of musculocontractural Ehlers-Danlos syndrome caused by dermatan sulfate epimerase deficiency (mcEDS-DSE): A detailed and comprehensive glycobiological and pathological investigation in a novel patient.

MLA

Minatogawa, Mari, et al. “Clinical and Pathophysiological Delineation of Musculocontractural Ehlers-Danlos Syndrome Caused by Dermatan Sulfate Epimerase Deficiency (McEDS-DSE): A Detailed and Comprehensive Glycobiological and Pathological Investigation in a Novel Patient.” Human Mutation, vol. 43, no. 12, Dec. 2022, pp. 1829–36. EBSCOhost, https://doi.org/10.1002/humu.24437.

APA

Minatogawa, M., Hirose, T., Mizumoto, S., Yamaguchi, T., Nagae, C., Taki, M., Yamada, S., Watanabe, T., & Kosho, T. (2022). Clinical and pathophysiological delineation of musculocontractural Ehlers-Danlos syndrome caused by dermatan sulfate epimerase deficiency (mcEDS-DSE): A detailed and comprehensive glycobiological and pathological investigation in a novel patient. Human Mutation, 43(12), 1829–1836. https://doi.org/10.1002/humu.24437

Chicago

Minatogawa, Mari, Takuya Hirose, Shuji Mizumoto, Tomomi Yamaguchi, Chiai Nagae, Masashi Taki, Shuhei Yamada, Takafumi Watanabe, and Tomoki Kosho. 2022. “Clinical and Pathophysiological Delineation of Musculocontractural Ehlers-Danlos Syndrome Caused by Dermatan Sulfate Epimerase Deficiency (McEDS-DSE): A Detailed and Comprehensive Glycobiological and Pathological Investigation in a Novel Patient.” Human Mutation 43 (12): 1829–36. doi:10.1002/humu.24437.